Categories
Pharmaceutical

Demand for Joint Reconstruction Is Set to Expand Modestly, Registering a Moderate CAGR of 4.0% By 2026

The global demand for orthopedic devices is set to expand modestly, registering a moderate CAGR of 4.0% throughout the forecast period (2020-2026).

A rapidly expanding geriatric population pool as well as increasing incidence rates of accidents and sports injuries are major factors contributing to the growth of the global orthopedic devices market. Moreover, technological advancements such as minimally invasive surgeries, artificial intelligence, 3D-bioprinting and tissue engineering, custom-made implants and development of variable axis screw systems are anticipated to provide a significant boost to the market.

However, the coronavirus pandemic is anticipated to limit growth prospects, with patients delaying elective surgical procedures in favor of treatment for COVID-19 infected patients. However, with social distancing measures being relaxed, the market is expected to witness a gradual resurgence, attributed to the restoration of production and manufacturing capacities of key industrial players, thus ameliorating the demand-supply gap.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4780

“Rising emphasis on technological innovations is anticipated to accelerate the growth of the global orthopedic devices market. Key manufacturers are exploiting this knowledge to develop new pipeline products,” infers a Fact.MR analyst.

global orthopedic devices market 02

Global Orthopedic Devices Market: Segmentation

Product

  • Joint Reconstruction:
    • Hip Replacement:
    • Total Hip Replacement Implant
    • Partial Hip Replacement Implant
    • Hip Resurfacing Implant
    • Revision Hip Replacement Implant
  • Knee Replacement:
    • Total Knee Replacement Implant
    • Partial Knee Replacement Implant
    • Revision Knee Replacement Implant
    • Elbow & Shoulder Replacement
    • Others
  • Spinal Devices:
    • Spinal Fusion Devices
    • Spinal Non-fusion Devices
  • Trauma Fixation:
    • Metal Plates & Screws
    • Pins/Wires
    • Nails and Rods
    • Others
  • Orthopedic Prosthetics:
    • Lower Extremity Orthopedic Prosthetics
    • Upper Extremity Orthopedic Prosthetics
    • Arthroscopy Devices
  • Orthopedic Braces and Support:
    • Upper Extremity Braces and Support
    • Low Extremity Braces and Support
  • Orthopedic Accessories:
    • Bone Cement
    • Casting System
    • Removal Systems
  • Others

End-User

  • Hospitals
  • Orthopedic Clinics
  • Ambulatory Surgical Centers
  • Others

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4780

Key Takeaways of Global Orthopedic Devices Market Study:

  • By product, the joint reconstruction segment shall dominate the market, acquiring a market share exceeding 30%. This is followed by the spinal devices segment, capturing 1/4th of the global orthopedic devices market. A large patient pool awaiting joint replacements and technological advancements in neurological surgeries are key growth drivers.
  • By end-user, orthopedic clinics are expected to gain significant traction. The segment is poised to expand 1.3x in the forecast period. However, the hospitals segment shall continue its dominance, capturing nearly half of the global orthopedic devices market.
  • By region, North America is expected to dominate the global orthopedic devices market, while Asia-Pacific shall expand the fastest. Growth in demand for orthopedic surgeries has attracted key market players to establish their businesses in North America while rising per capita healthcare expenditure is stimulating market growth in Asia-Pacific.

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4780

Following Questions Answers Covered in the Report are:

  • How will the global Orthopedic Devices Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Orthopedic Devices Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Orthopedic Devices Market?
  • How will these strategies influence the market growth and competition?

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –https://www.biospace.com/article/increasing-r-and-d-and-improved-healthcare-spending-are-key-factors-pushing-development-of-waldenstrom-macroglobulinemia-market-growth-states-fact-mr/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Robust Product Portfolio, Key to Market Players’ Strong Presence:

The global orthopedic devices market is consolidated, dominated by the following top four players: Zimmer Biomet, Johnson & Johnson, Stryker and Smith & Nephew. Collectively, these companies account for nearly 55% of the market share. Therefore, the degree of competition from new entrants is quite low. Innovations in 3D printing and personalization implants technology are anticipated to fuel the growth of emerging players in the hip implants sub-segment. Important players in the hip implants segment include Smith & Nephew, DJO Global, Inc., Wright Medical Group N.V., and Exactech, Inc.

In 2017, Zimmer Biomet Holdings dominated the hip implants sub-segment, with a strong brand image and robust product portfolio. Its products included the Taperloc Hip System, the Arcos Modular Hip System and the G7 Acetabular System. Likewise, Stryker has a robust product portfolio, offering devices in the craniomaxillofacial, foot & ankle, joint replacement, spine and trauma & extremities segments. Its brands are Allograft Bio Implants, Delta, Advanced Midface Distractor and MEDPOR TITAN 3D Orbital Floor to name a few.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Glaucoma Alpha Agonists Healthcare Industry Insights: Prostaglandins are Anticipated to Account for the Maximum Market Share

Rising prevalence of glaucoma and other visual impairments have led to an increase in the demand for therapeutic drugs to treat these conditions. Around one-tenth of the elderly population suffers from glaucoma, which is expected to increase with each passing year. Consequently, the demand for better therapy options for the treatment of glaucoma is expected to boost demand for therapeutics.

On the back of these factors, the global glaucoma therapeutics market shall witness a gradual growth, at a CAGR of 2.9% during the forecast period (2020-2026). Other generic drivers, such as a greater geriatric population pool, a rise in the diabetic population and higher healthcare spending and infrastructure shall boost market growth.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4775

“The glaucoma therapeutics market shows a positive growth trend. Its market is expected to be invigorated by continuous research and product development, especially in combination drugs. Leading market players have accordingly developed formulae which can assist in faster recovery of glaucoma patients,” concludes a Fact.MR analyst.

glaucoma therapeutics market 02

Global Glaucoma Therapeutics Market: Segmentation

Drug Class

  • Prostaglandins
  • Beta Blockers
  • Alpha Agonists
  • Carbonic Anhydrase Inhibitors
  • Combination Medications
  • Cholingerics

End-users

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4775

Key Takeaways of Global Glaucoma Therapeutics Market Study

  • Prostaglandins are anticipated to account for the maximum market share of the glaucoma therapeutics market. This is attributed to its increased adoption in first line glaucoma treatment. The drug reduces intraocular pressure (IOP) by increasing uveoscleral flow. Projections indicate a market share of more than two-fifth of the total glaucoma therapeutics market.
  • Combination medicines are becoming more prevalent for glaucoma treatment. Greater effectiveness of treatment over individual medications is a key growth driver for this segment. For example, the Rhopressa drug class, a combination formula developed by Aerie Pharmaceuticals, has been approved for usage in commercial glaucoma treatment. Projected CAGR for combination medicines is pegged at 4.7% during the forecast period.
  • Hospitals shall account for the majority of the share of glaucoma therapeutics between 2020 and 2026. Increasing number of patients coupled with the ability to provide optimum healthcare services are major growth drivers.
  • North America is set to remain a lucrative market for glaucoma therapeutics. Increased focus on research and development of therapeutic drugs and approvals of certain drug categories like Rhopressa are expected to leverage the region’s market share. Asia-Pacific is following close behind, with a projected CAGR of 3.2% during the forecast period. Introduction of new drugs like Travopost and Timolol are expected to invigorate Asia-Pacific’s market share.

Following Questions Answers Covered in the Report are:

  • How will the global Glaucoma Therapeutics Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Glaucoma Therapeutics Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Glaucoma Therapeutics Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4775

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights – https://www.biospace.com/article/emergence-of-pharma-tech-and-new-product-launches-is-driving-growth-of-global-analytical-gel-permeation-chromatography-market-notes-fact-mr/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Combination Drugs; a Growth Lever for Market Players

The global glaucoma therapeutics market consists of the following market players: Allergan plc, Merck & Co., Inc., Novartis AG, Pfizer Inc., Santen Pharmaceuticals Co. Ltd., Valeant Pharmaceuticals, Inc. and Aerie Pharmaceuticals, Inc. Novartis AG’s Alcon division focuses on development of eye care products, such as Travatan, Simbrinza and Azarga. Allergan Plc., occupies the second position in the market, and include top selling brands like Lumigan, Alphagan, Ganfort and Combigan. More recently, the company also received an approval from the FDA to launch its DURYSTATM Biodegradable Sustained-Release Implant. This device is designed to reduce intraocular pressure in open-angle glaucoma or ocular hypertension patients.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Radioimmunoassay (RIA) Is Poised to Register a Positive Growth Trend, Expanding at a CAGR of 6.0% | Report Fact.MR

According to Fact.MR’s Study, As the number of chronic and infectious diseases compound, medical advancements have grown in equal proportion. The global Demand for immunoassays is poised to register a positive growth trend, expanding at a CAGR of 6.0% throughout the forecast period (2020-2026).

Medical practitioners are increasingly relying on analyzer technique such as enzyme-linked immunosorbent assay (ELISA), immunofluorescent assay (IFA) and chemiluminescence immunoassay (CLIA) to detect infectious pathogens.

The novel coronavirus pandemic is an area where the immunoassay market shows promising developments. Key players have been conducting extensive research with the onset of the disease to determine possible antibodies to counter the virus. For instance, in April 2020, Bio-Rad Corporation announced the introduction of a blood-based immunoassay kit for the identification of antibodies for coronavirus. Besides, diagnosis of autoimmune diseases has also found increased applications of immunoassay treatments.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4766

“The global immunoassay market is poised to register positive growth in the future, burgeoned by increasing adoption of testing against the backdrop of rising prevalence of chronic and infectious diseases. In addition, the coronavirus pandemic is anticipated to provide further stimulus to the immunoassay testing market,” concludes a Fact.MR analyst.

Key Takeaways of Global Immunoassay Market Study:

  • By technology, chemiluminescence immunoassay (CLIA) shall capture nearly half of the global immunoassay market during the forecast period, expanding at a CAGR of 6.6% across the forecast period. Following behind is the enzyme-linked immunosorbent assay (CLIA), accounting for more than 30% of the market.
  • By product, the consumables segment shall capture greater than 4/5th of the global immunoassay market. Wide usage of immunoassays in diagnosing infectious diseases and endocrine disorders is driving the consumables segment growth.
  • By application, both endocrinal disorders and infectious diseases segment shall expand at a CAGR of 6.5% each, capturing 17.1% and 29.3% market shares respectively. Widespread applications of endocrinal testing for several disorders shall leverage growth prospects for endocrinal disorders while the ongoing COVID-19 pandemic is leveraging the infectious diseases segment.
  • By end-user, hospitals are anticipated to capture the majority of the market share (~81%) while blood banks shall expand the fastest, at a CAGR of nearly 7.0%. Increasing number of immunoassay tests in hospital settings is anticipated to drive the hospitals segment while increased demand for blood transfusions for curing infectious diseases is anticipated to leverage the blood banks segment.
  • By region, North America shall remain the supreme leader, accounting for nearly two-fifths of the global immunoassay market. However, Asia-Pacific promises to offer lucrative opportunities, expanding at a CAGR of 7.0%. Mergers and acquisitions among leading manufacturers and burgeoning investments in the life sciences and healthcare industry are key growth determinants in both regions.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4766

Global Immunoassay Market: Segmentation

Technology

  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme-linked Immunosorbent Assay (ELISA)
  • Enzyme Linked Fluorescence Assay (ELFA)
  • Radioimmunoassay (RIA)
  • Others

Product

  • Analyzer
  • Consumables

Application

  • Infectious Diseases
  • Endocrinology
  • Oncology
  • Cardiology
  • Orthopedics
  • Others

End-user

  • Hospitals & Diagnostic Laboratories
  • Blood Banks
  • Others (Pharmaceutical & Biotech Companies, Academic & Research Institutes, Forensic Labs, etc.)

Following Questions Answers Covered in the Report are:

  • How will the global Immunoassay Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Immunoassay Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Immunoassay Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4766

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –https://www.biospace.com/article/increased-awareness-about-women-health-is-key-for-driving-global-conjugated-estrogen-market/

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Global Immunoassay Market: Competition Structure:

The global immunoassay market is highly consolidated. The top four market players constitute more than half of the total market share. These players are: F. Hoffmann La-Roche Ltd. (Roche Holdings AG), Abbott Laboratories, Siemens Healthineers and Beckman Coulter, Inc. (Danaher).

These players have consolidated their operations by virtue of important collaborations to burgeon production of immunoassay kits. La-Roche, for instance, offers products such as the COBAS C 702 & E 602 Module, the COBAS 4000 & 6000 Analyzer series and Elecsys Assays.

Likewise, Abbott Laboratories offers biotin-free assays to prevent interference in testing and the resulting inaccuracies. Other prominent immunoassay players include DiaSorin S.p.A., Sysmex Corporation, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company and Merck KGaA.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Endoscopy Fluid Management Is Set to Expand In The Wake of Increasing Incidence of End-Stage Renal Diseases : Latest Report Fact.MR

Fluid management is an integral component of patient care. It entails regulation and maintenance of overall fluid levels within the body. Each patient’s individual fluid needs differ, making the process extremely delicate. Fluid Management has shown increased application among patients suffering from end-stage renal disease (ESRD), an adverse condition arising out of diabetes.

Since kidney function drops to only 10-15% in this stage, it becomes very important to manage the fluid build-up inside the blood. On the back of this trend, the global demand for fluid management is anticipated to register a moderate growth of 5.3% during the forecast period (2020-2025)

“The global fluid management market is set to expand in the wake of increasing incidence of end-stage renal diseases, an anomaly arising out of diabetes. Continuous research and development of next-generation infusion devices is an important approach by leading manufacturers to consolidate their presence in the market,” concludes a Fact.MR analyst.

For More Insights Into The Market, Request a Sample of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=4763

Key Takeaways of Global Fluid Management Market Study:

  • Infusion therapy is set to dominate the global fluid management market, capturing more than half of the total market share. Demand for intravenous fluid administration to dehydrated patients unresponsive to oral therapy is poised to steer the market forward.
  • The renal products segment is anticipated to catch up, expanding at a CAGR of 5.5%. Increasing number of kidney patients has augmented the need for dialysis procedures and devices such as renal disposables and ancillaries, saline solutions & concentrates and dialysis accessories. This is foreseen to bolster the segment’s growth.
  • By end-user, hospitals are anticipated to capture maximum market share, amounting for almost two-fifth. Rising cases of chronic kidney infections are pushing people to seek treatment, thus augmenting growth. The segment is projected to expand 1.3x throughout the forecast period.
  • North America shall remain the kingpin in the global fluid management market, attributed to rising prevalence of lifestyle diseases, launch of next-generation infusion devices and a burgeoning demand for smart pumps. The infusion therapy segment shall account for more than half of the North American fluid management market.
  • However, Asia-Pacific shows promising growth prospects. Prevalence of typhoid, malaria and cholera which requires continuous fluid administration, as well as rising cases of ESRD are projected to leverage the Asia-Pacific market. The region is anticipated to expand 1.5x, at a CAGR of 7.0% throughout the forecast period.
  • Fluid management is poised to find increased application during the COVID-19 pandemic. Provision of hemodynamic support and reduction in the incidence of pulmonary edema are two important applications of fluid management amongst COVID-19 patients.
  • Important market players are extensively engaged in providing top-of-the-line solutions to medical practitioners for coping with the pandemic. To this end, Baxter Healthcare is concentrating on ensuring a steady supply of its products. The company proactively manages inventory levels, stock levels in warehouses and transportation options.
  • Baxter is also providing financial support to multiple groups addressing patient needs. It does so through its Baxter International Foundation. Dialysis supplies are also being augmented in order to cater to renal disorder patients.
  • Stryker Corporation, another market player, has released its Emergency Relief Bed, a limited-release medical bed to support critical needs during the pandemic. The bed features a 30-degree head of bed angle to accommodate patients in respiratory distress. It also features low height and an attached IV pole.

Share Your Requirements & Get Customized Reports – https://www.factmr.com/connectus/sample?flag=RC&rep_id=4763

Global Fluid Management Market: Segmentation

  • Application
    • Urology
    • Cardiology
    • Orthopedic/Osteology
    • Neurology
    • Oncology
    • Gastroenterology
    • Others (Anesthesiology, Bronchology, Dentistry, Otology and Gynecology)
  • End-users
    • Hospitals
    • Clinics
    • Dialysis Centers
    • Home Care Settings
    • Others
  • Key Regions
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa

Following Questions Answers Covered in the Report are:

  • How will the global Fluid Management Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Fluid Management Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Fluid Management Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4763

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

Get More Insights –https://www.biospace.com/article/facial-spasm-treatment-demand-augmented-by-growing-awareness-of-the-treatment-options-says-fact-mr

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Infusion Products to Act as Key Growth Levers for Market Players

The global fluid management market comprises of a number of key companies. Prominent manufacturers with established market presence in global fluid management market are Baxter, C.R. Bard, Inc., BD, Smith & Nephew, B. Braun Holding GmbH & Co. KG, Fresenius SE & Co. KGaA, Cardinal Health Inc., Stryker, Boston Scientific Corporation and Karl Storz GmbH.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Standalone Indirect Calorimeters to Soar with High Growth Observed in Asia Pacific Unveils Fact.MR

This particular market is one of the few to benefit from the COVID-19 pandemic. Hospitals have shown significant increase in the demand for indirect calorimeters, especially standalone calorimeters meant for critical care units. On the other hand, portable calorimeters have also seen a rise in demand from research institutes due to inclined interest in research & development by key players in this market space.

Backed by advancements in technologies of indirect calorimeters, the market is expected to witness tremendous growth due to the cost effectiveness and convenience factor of these products, especially portable indirect calorimeters. Indirect calorimeters have several applications in monitoring a patient’s metabolic activities, which further helps doctors provide effective treatment. Thus, wider application of indirect calorimeters coupled with increasing number of hospital admissions will favor the growth of the global indirect calorimeter market over the forecast timeframe, which is projected to expand at a CAGR of 4% through 2030.

To remain ‘ahead’ of your competitors, request for a sample
https://www.factmr.com/connectus/sample?flag=S&rep_id=5108

“Increased sales of portable indirect calorimeters will boost market revenue over the coming years,” says a Fact.MR analyst.

indirect calorimeter market competitive analysis

Key Takeaways from Indirect Calorimeter Market Study

  • Investments in advanced technologies of indirect calorimeters will act as an important driver, increase 1.5x value by 2025.
  • Hospitals are the leading end user segment, accounting for 30% share in the indirect calorimeter market, due to significant increase in demand.
  • North America is a dominant region in the market, and accounts for 40% of the total revenue share.
  • Regions such as Asia are predicted to see significant growth in the indirect calorimeter market, based on exponential increase in population and rising medical tourism in the region.
  • The market is moderately consolidated in nature, with key players being COSMED, MGC Diagnostics, and KORR medicals, having a cumulative share of approximately 40% in the market.

Speak To Research Analyst For Detailed Insights:
https://www.factmr.com/connectus/sample?flag=AE&rep_id=5108

Indirect Calorimeter Market Segmentation

Fact.MR has studied the indirect calorimeter market with detailed segmentation on the basis of type, end user, and key regions.

Type

  • Standalone Indirect Calorimeters
  • Portable Indirect Calorimeters

End User

  • Hospitals (Critical Care Units)
  • Research Institutes
  • Diagnostic Centers
  • Others (Sports Centers)

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

For critical insights on this market, request for methodology here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=5108

Approval of Latest Indirect Calorimeters to Boost Market Revenues

COSMED, a leading player in the indirect calorimeter market, recently collaborated with the ICALIC Clinical Trial study group for Q-NRG+ indirect calorimeters, which got approved by the FDA, This collaboration has developed an accurate system that is simple to use, is able to solve all typical disadvantages of indirect calorimetry technology, and has a considerable improvement in functionality as compared to older and outdated products, thereby providing a significant boost to the growth of the market.

More Valuable Insights on Indirect Calorimeter Market

Fact.MR, in its new offering, presents an unbiased analysis of the global indirect calorimeter market, presenting historical demand data (2015-2019) and forecast statistics for the period of 2020-2030. The study divulges essential insights on the indirect calorimeter market on the basis of type (standalone indirect calorimeters, portable indirect calorimeters), end user (hospitals, critical care units, research institutes, diagnostic centres, sport institutes), and major regions of the world (North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa).

Key Prominent Players

  • Cosmed S.R.L
  • MGC Diagnostics
  • Microlife USA
  • KORR Medical Technologies
  • Maastricht Instruments BV
  • Vyaire Medical
  • Parvo Medics
  • GE Healthcare

Explore Fact.MR’s Coverage on the Healthcare Domain

Laser Cancer Therapy Market: A recent study by Fact.MR on the Laser Cancer Therapy Market offers a 5-year forecast analysis for the period 2017 – 2022. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Cancer Immunotherapy Market: Fact.MR’s extensive coverage of the Cancer Immunotherapy Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Hyperthermia Cancer Treatment Market: The Hyperthermia Cancer Treatment Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Will Japan’s Liquid-Based Fiducial Markers Market Exhibit Hegemony : Check Fact.MR’s Latest Study

Fiducial markers sales are anticipated to surpass 100 Mn by 2019, registering an upswing from 93.9 Mn in 2018, according to a Fact.MR study. As fiducial markers gain traction in parallel to rising incidences of various cancer forms affecting lung, prostate, abdomen and kidney, the growth potential of the market is set to witness a considerable rise. The escalating demand for fiducial markers can be accredited to,

  • Growing adoption of radiotherapy devices by oncologists
  • Surging demand for IGRT and SBRT procedures
  • Versatility of fiducial markers in effective diagnosis
  • Increasing rates of cancer across the globe

Click HERE To get a SAMPLE PDF (Including Full TOC, Table & Figures) at
https://www.factmr.com/connectus/sample?flag=S&rep_id=1026

“Cancer survivors are increasingly opting for radio therapy procedures, either for primary management or for symptom control. This rise in embracement of radiotherapy as an effective methodology for diagnosis and management of cancer is substantially spurring sales of fiducial markers”, Senior Analyst, Fact.MR

With the adoption of fiducial markers as a standard tool for image-guided radiotherapy, manufacturers are coming across huge demand. According to a report titled “Radiotherapy in Global Cancer Control” published by the Cancer Control Organization, availability of radiotherapy equipment varied from 8.6 machines per million people in high-income countries (as per the World Bank definition) to 1.6 per million in high-middle income, 0.71 in low-middle income countries, and 0.21 per million in low-income countries. This data reveals the growth scope for fiducial markers over the coming years.

fiducial markers market competition

Need more information about Report Methodology? Click here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=1026

Key Takeaways from Fiducial Markers Market Study

  • Germany remains the leading country in the world’s largest market for fiducial – Europe
  • The United States will remain the epicenter of the world’s largest fiducial markers market – North America – with a share of more than 85% in the region.
  • China, Japan, Indonesia, and others to remain highly sought-after markets for suppliers.
  • High demand for pure gold fiducial markers to fuel sales.
  • Growing requirement of photon therapy to propel growth of fiducial manufacturers.
  • In terms of disease site, prostate cancer to emerge as a dominant segment.
  • Radiotherapy centers to lead market demand in terms of end user.

Segmentation by Category

Product

  • Polymer Based Markers
  • Metal Based Markers
  • Pure Gold Markers
  • Liquid Based Markers

Modality

  • Photon Therapy
  • Proton Therapy
  • Tomotherapy
  • Cyberknife

Disease Site

  • Head & Neck
  • Breast
  • Lung
  • Abdomen
  • Prostate
  • Kidney
  • Cervix or Other Gynaecologic Organs

End User

  • Hospitals
  • Cancer Research Institutes
  • Radiotherapy Centers

Region

  • North America
  • Latin America
  • Europe
  • Middle East and Africa (MEA)
  • East Asia
  • South Asia
  • Oceania

Full Access of this Exclusive Report is Available at- https://www.factmr.com/checkout/1026

Rise in Cases of Cancer Fuelling Sales of Fiducial Markers

As fiducial markers are an integral part of radiation therapy for cancer patients, rise in cases of cancer is fuelling sales. As per a report published by The International Agency for Research on Cancer (IARC) in December 2020, globally, 1 in 5 people develop cancer during their lifetime, while the fatality rate is 1 in 8 for men and 1 in 11 for women. The report also stated that, more than 50 million people are living within 5 years of a past cancer diagnosis.

According to a report published by the World Health Organization (WHO) on 12th September 2018, cancer is the second-leading cause of death globally, and was responsible for an estimated 9.6 million deaths in 2018. While this data represents the high fatality rate of cancer, it also signifies huge demand for various medical devices and equipment for its diagnosis and treatment, of which, fiducial markers play a huge role.

For More Insights

https://www.newswire.co.kr/newsRead.php?no=922809

Who is Winning in this Space?

As key market players are investing more, competition is getting tougher gradually in the fiducial markers market space. In order to leverage new opportunities, key players are diversifying their products.

For instance,

  • Boston Scientific launched its new LumiCoil™ Platinum Fiducial Markers, which are designed for clear visibility in CT, X-ray, EUS, and others, in January 2018.
  • Stellar Medical launched its new range of fiducial markers, such as Stellar Gold Fiducial Markers, Soft Tissue Implantable Gold Fiducial Markers, and others, in 2019.
  • Eckert & Zieglar BEBIG
  • Innovative Oncology Solutions
  • Boston Scientific
  • IBA
  • Best Medical International, Inc.
  • IZI Medical Products
  • Carbon Medical Technologies
  • CIVCO
  • AlphaXRT
  • Nanovi A/S
  • Stellar Medical

Explore Fact.MR’s Coverage on the Healthcare Domain

Laser Cancer Therapy Market: A recent study by Fact.MR on the Laser Cancer Therapy Market offers a 5-year forecast analysis for the period 2017 – 2022. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Cancer Immunotherapy Market: Fact.MR’s extensive coverage of the Cancer Immunotherapy Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Hyperthermia Cancer Treatment Market: The Hyperthermia Cancer Treatment Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions.We have offices in US and Dublin, whereas our global headquarter is in Dubai.While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise.Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed.Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Retail Pharmacies Are Expected to Account for 3/4th of the Atopic Dermatitis Corticosteroids Drugs Market Share :Report Fact.MR

Dermatological disorders are increasing with each passing day. The World Health Organization estimates that more than 900 million people are suffering from skin ailments since 2017. Atopic dermatitis accounts for a major chunk of these illnesses, with more than 300 million people, mostly children, affected by it. Based on the aforementioned trends, the global demand for atopic dermatitis drugs is expected to register astounding growth of 24% between 2020 and 2027.

Research and development in manufacturing novel drugs, rising demand for biologics and product approvals are other factors augmenting market growth. On this premise, the atopic dermatitis market is poised to surpass a valuation of US$ 19 Bn by the end of the forecast period.

For detailed insights on enhancing your product footprint, request a sample here-
https://www.factmr.com/connectus/sample?flag=S&rep_id=4603

“The global atopic dermatitis drugs market demonstrates exceptional potential in the future. Increasing incidence of dermatological disorders, combined with intensive research and development in novel pipeline drugs, is expected to propel market share,” concludes a Fact.MR analyst

A detailed assessment of global atopic dermatitis drugs market value chain analysis, business execution, and supply chain analysis across the regional markets has been covered in the report. A list of prominent companies operating in the global atopic dermatitis drugs market along with their product portfolio enhances the reliability of this comprehensive research study.

atopic dermatitis market 01

Key Takeaways of Global Atopic Dermatitis Drugs Market Study

  • Biologics Drugs is the leading segment by drug class. Projected CAGR for the same is pegged at a staggering CAGR of 32.1% during the forecast period. New product launches and increased adoption of Biologics drugs are key factors driving the growth of the segment.
  • PDE4 Inhibitors closely follow the biologics drugs segment, registering a whopping CAGR of 31.1%. Increased affordability of treatment and intensive research and development are expected to drive the growth of PDE4 Inhibitors.
  • Retail Pharmacies are expected to account for three-fourth of the market share for atopic dermatitis drugs. Increased number of retail pharmacies, easy availability of therapeutic drugs and convenience are some contributing factors.
  • North America shall retain its dominance in the atopic dermatitis drugs market. Adoption of advanced biologics drugs, adequate reimbursement coverage for pharmaceutical companies and greater market penetration of new players are some major growth stimulators. The region is set to expand at a CAGR of 27% during the forecast period.
  • Europe is the second most attractive market, accounting for around one-third of the global atopic dermatitis drugs market. This is due to increased awareness about the disease, favorable medical reimbursement policies and well-established healthcare facilities.

For comprehensive insights on this market adoption, ask an analyst here-
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4603

Global Atopic Dermatitis Drugs Market Segmentation

Fact.MR has studied the global atopic dermatitis drugs market with detailed segmentation on the basis product type, application and key regions.

Drug Class Distribution Channel Key Regions
Corticosteroids Hospital Pharmacies North America
PDE4 Inhibitors Retail Pharmacies Europe
Biologics Online Pharmacies Asia Pacific
Skin Barrier Emollients Latin America
CNI Immunosuppressants Middle East & Africa
Others

For in-depth competitive analysis, buy now-
https://www.factmr.com/checkout/4603

Development of Novel Drugs to Determine Market Competitiveness

Investments in development of novel pipeline drugs is expected to shape the global atopic dermatitis drugs market competitiveness. An example for this is the development of the biologics drug DUPIXNET ® by Sanofi Genzyme, which cures skin lesions and reduces itching. It does so by inhibiting secretions of interleukin-4 (IL-4) and interleukin-13 (IL-13) protein strains, responsible for type 2 skin inflammation. Likewise, Eucrisa (crisaborole), developed by Pfizer, Inc., consists of PDE4 Inhibitors to treat skin ailments like Eczema. It works by controlling the over-reactive parts of the PDE4 enzyme within skin cells to prevent inflammation.

Looking for more information?

The research study on the global atopic dermatitis market by Fact.MR incorporates an unbiased assessment of key factors and trends responsible for shaping the landscape of the global atopic dermatitis market over 2020-2027. It includes a detailed assessment of key parameters that are anticipated to exert influence during 2020-2027. Market statistics have been presented on the basis of Drug Class (Corticosteroids, PDE4 Inhibitors, Biologics, Skin Barrier Emollients, CNI Immunosuppressants and Others.) and Distribution Channels (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies) across five major regions.

For More Insights: https://www.newswire.co.kr/newsRead.php?no=922175

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

What are the Key Strategies Adopted by Players to Sustain Themselves In The Radiolucent Imaging Tables: A Report By Fact.MR

According to the Fact.MR’s Study, Towards the end of 2022, the global market for patient positioning will have expanded steadily at 6.1% CAGR, raking revenues worth slightly over US$ 1.9 Bn.

Patient’s dignity and comfort are of paramount importance in the field of medical surgery. Nurses are properly trained on patient positioning principles, and hospitals are also compelled to be equipped with leading products that can facilitate effective patient positioning.

The Fact.MR forecast report on global sales of patient positioning projects that the market will reach US$ 1.4 Bn value by the end of 2017. With improving healthcare infrastructures and adoption of ergonomic designs, manufacturers of patient positioning products are likely to boost their capacity in the years to come.

For More Insights Into The Market, Request a Sample of this Report –

https://www.factmr.com/connectus/sample?flag=S&rep_id=52

The report has also outlined the competitive landscape of global market for patient positioning systems, which includes

  • Mizuho OSI
  • LEONI AG
  • C-RAD, Elekta AB(publ)
  • Skytron
  • Span-America Medical Systems, Inc.
  • STERIS plc.
  • Stryker Corporation
  • Hill-Rom, Inc.

Key Forecast Highlights

  1. According to the report, tables will account for nearly 20% share on global patient positioning revenues in 2017. Surgical tables, on the other hand, will be observed as top-selling products in the global patient positioning market. By the end of 2022, nearly US$ 500 Mn worth of revenues will be procured from sales of patient positioning surgical tables around the world.
  2. Increasing emphasis on improving the healthcare infrastructure has propelled the adoption of patient positioning solutions in developing regions. Manufacturers of patient positioning are also viewing regions such as the Asia-Pacific excluding Japan (APEJ) region lucrative for setting up manufacturing units. High resource availability, low wage costs, coupled with dense population that translates into maximum end-use, are driving the growth of patient positioning market in the APEJ region. The report projects that the APEJ patient positioning market will soar vigorously at 7.2% CAGR, bringing in revenues worth over US$ 238 Mn by the end of 2022.
  3. North America is expected to remain the largest market for patient positioning. The report predicts that high healthcare spending in the US and Canada will prompt manufacturers in providing top-of-line products in the field of patient positioning. While revenues amassed from sales of patient positioning products in Europe will contribute to 30% of global market value, it is estimated North America’s patient positioning market will procure nearly US$ 480 Mn revenue towards the end of 2017.
  4. Surgeries are estimated to be the largest application of patient positioning products. The report expects that in 2017, a little over US$ 485 Mn worth of patient positioning products will be sold in surgical applications. Application of patient positioning solutions in cancer therapy will also be of equivalent traction in the global market, accounting for more than 38% share on global revenues through 2022.
  5. Demand for patient positioning is also expected to gain traction across diagnostic centers. While hospitals will remain the largest end-users of patient positioning products, their end-use in diagnostic centers are expected to procure more than US$ 488 Mn revenue by 2022-end.

Share Your Requirements & Get Customized Reports –

https://www.factmr.com/connectus/sample?flag=RC&rep_id=52

Market Taxonomy

By Product By End User By Application
Tables Hospitals Surgery
Surgical Tables Ambulatory Surgical Centers Diagnostics & Imaging
Radiolucent Imaging Tables Diagnostic Centers Cancer Therapy
Examination Tables Others
Accessories
Other Patient Positioning Systems

Get More Insights –

https://www.newswire.co.kr/newsRead.php?no=925421

A market research study is incomplete without regional analysis, and we are well aware of it. That is why, the report includes a comprehensive and all-inclusive study that solely concentrates on the geographical growth of the global Patient Positioning Market. The study also includes accurate estimations about market growth at the global, regional, and country levels. It empowers you to understand why some regional markets are flourishing while others are seeing a decline in growth. It also allows you to focus on geographies that hold the potential to create lucrative prospects in the near future.

Following Questions Answers Covered in the Report are:

  • How will the global Patient Positioning Market perform during the forecast period? What will be the market size in terms of value and volume?
  • Which segment will drive the global Patient Positioning Market? Which regional market will show extensive growth in the future? What are the reasons?
  • How will the market dynamics change because of the impact of future market opportunities, restraints, and drivers?
  • What are the key strategies adopted by players to sustain themselves in the global Patient Positioning Market?
  • How will these strategies influence the market growth and competition?

Access Research Methodology Prepared By Experts – https://www.factmr.com/connectus/sample?flag=RM&rep_id=52

Regional analysis includes

  • North America (U.S., Canada)
  • Latin America (Brazil, Mexico, Argentina, Chile, Peru, Rest of LATAM)
  • EU – (Germany, France, Italy, Spain), UK, BENELUX (Belgium, Netherlands, Luxemburg), NORDIC (Norway, Denmark, Iceland, Sweden), Eastern Europe (Poland, Ukraine, Czech Rep. etc.), Rest of Europe
  • CIS & Russia
  • Japan
  • Asia Pacific Excluding Japan (Greater China, India, S. Korea, ASEAN Countries, Rest of APEJ)
  • Middle East and Africa (GCC Countries, Turkey, Iran, Israel, South Africa , Rest of MEA)

The Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Explore Fact.MR’s Coverage on the Healthcare Domain

Laser Cancer Therapy Market: A recent study by Fact.MR on the Laser Cancer Therapy Market offers a 5-year forecast analysis for the period 2017 – 2022. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Cancer Immunotherapy Market: Fact.MR’s extensive coverage of the Cancer Immunotherapy Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Hyperthermia Cancer Treatment Market: The Hyperthermia Cancer Treatment Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

North America Dominates Chylothorax Pleural Catheters With A Healthy CAGR of 6.4% Over The Next 10 Years

According to Fact.MR’s Study, Global Sales of Pleural catheters was valued at US$ 22.6 Mn in 2018, and is expected to witness a healthy CAGR of 6.4% during the forecast period (2019 – 2029).

The use of pleural catheters is gathering momentum globally owing to its proven efficacy as a treatment solution for malignant pleural effusions when pleurodesis has failed or is contraindicated. Pleural catheters are being used as a frontline therapy in order to improve patient quality of life, patient safety and clinician efficiency. Freedom from hospital admissions and effective symptomatic relief with minimum interventions are some of the critical factors propelling the growth of the pleural catheters market.

To remain ‘ahead’ of your competitors, request for a sample

https://www.factmr.com/connectus/sample?flag=S&rep_id=3128

“Significant morbidity reduction, prompt hospital discharge, less risk of re-intervention coupled with same-day outpatient procedures, performed by home healthcare provider or a trained family member are the key factors which paves the way for frontline therapy for pleural infection patients” says the Fact.MR Analyst

Pleural catheters have gained clinical significance on the back of their effective fluid control and improved dyspnea, affordability and its efficacy as a minimally invasive procedure. Outpatient procedures, reduction in associated risk, cost and hospitalization have prompted the expansion of the pleural catheters market. Moreover, inclination towards the use of pleural catheters, growing prevalence of pleural effusion and rising cases of COPD in emerging regions are the factors driving the market growth.

global pleural catheters market 01

Key Takeaways of Pleural Catheters Market Study

  • Malignant Pleural Effusions emerged as the largest segment by indication type representing 75% of revenue share in the pleural catheters market. This is attributed to the viable alternative management strategy and its most frequently utilization in the clinical management of pleural infection, both malignant and benign effusion
  • Hospitals accounted for a majority of the revenue share of 65% owing to the availability of pleural catheters and skilled personnel for better clinical management of patients with pleural infection
  • Cumulatively, North America and Europe contribute more than 60% of market share in pleural catheters market with North America holding a noteworthy market share and the regional market is expected to grow at a CAGR of 7.3% during the forecast period
  • Increasing number of thoracic surgeries performed are increasing prevalence of pleural diseases and thus giving an uptick to the demand for pleural catheters.

Speak To Research Analyst For Detailed Insights: 

https://www.factmr.com/connectus/sample?flag=AE&rep_id=3128

Key Segments of Pleural catheters Market

Indication
  • Malignant Pleural Effusions
  • Non-Malignant Recurrent Effusions
  • Chylothorax
  • Empyema
  • Haemothorax
End User
  • Hospitals
  • Ambulatory Surgical Centers
Region
  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

The study also includes statistics as well as facts related to macroeconomic as well as microeconomic factors that are impacting key developments in the market. It also offers actionable insights based on the future trends in the pleural catheters market. Furthermore, small businesses and new entrants in the pleural catheters market too can make use of the information presented in this study, based on which, they can make appropriate business decisions to gain momentum in the market.

For critical insights on this market, request for methodology here-
https://www.factmr.com/connectus/sample?flag=RM&rep_id=3128

Key Questions Answered in Fact.MR Pleural catheters Market Report

Which regions will continue to remain the most profitable regional markets for pleural catheters market players?
Which factors will induce a change in the demand for pleural catheter manufacturers during the assessment period?
How will changing trends impact the pleural catheters market?
How can market players capture the low-hanging opportunities in the pleural catheters market in developed regions?
Which companies are leading the pleural catheters market?
What are the winning strategies of stakeholders in the pleural catheters market to upscale their position in this landscape?

Pleural Catheters Manufacturers Strategically Focus on New Product Launches

Continuous upgradation and product launches in pleural catheters market are responsible for intense competition among the market players. Numerous organizations are focusing on new product approvals for pleural catheters. For example, in February 2018, Merit Medical launched Aspira® Drainage System which is a tunneled, long-term catheter used to drain accumulated fluid from the pleural or peritoneal cavity to relieve symptoms associated with malignant pleural effusion or malignant ascites. The system allows patients to drain fluid and manage their symptoms without repeated trips to the hospital. These winning strategies by leading players are also followed by regional and local players.

For More Insights

https://www.newswire.co.kr/newsRead.php?no=926964

Looking for more information?

The research study on the pleural catheters market by Fact.MR incorporates an unbiased assessment of key demand-driving factors and trends, which have shaped the landscape of the pleural catheters market over 2014 – 2018 and includes a detailed assessment of key parameters that are anticipated to exert influence during 2019 – 2029. Market statistics have been presented on the basis of indication (Malignant Pleural Effusions, Non-Malignant Recurrent Effusions, Chylothorax, Empyema, Haemothorax), and end user (hospitals and ambulatory surgical centers) across major countries of key regions.

Explore Fact.MR’s Coverage on the Healthcare Domain

Laser Cancer Therapy Market: A recent study by Fact.MR on the Laser Cancer Therapy Market offers a 5-year forecast analysis for the period 2017 – 2022. The study analyzes key trends that are currently influencing the growth of the market. This report covers key dynamics, including drivers, restraints, and opportunities for leading market players along with key stakeholders and emerging players.

Cancer Immunotherapy Market: Fact.MR’s extensive coverage of the Cancer Immunotherapy Market offers in-depth insights into the prominent growth dynamics that are likely to aid the expansion of growth prospects in the near future. Data has been presented in the form of key segments across prominent geographies, along with important information concerning key manufacturers operating within the industry.

Hyperthermia Cancer Treatment Market: The Hyperthermia Cancer Treatment Market study published by Fact.MR offers an unbiased analysis of the prominent drivers, opportunities, and trends expected to shape future expansion outlooks. The report provides a comprehensive assessment of the prominent segments and geographies which are likely to benefit market players in the forthcoming years.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Injectable Bone Graft Substitutes Market will Record Ascending Growth during 2031 with APEJ Record a Robust Growth

Injectable Bone Graft Substitutes Market size is done based on a triangulation methodology that is primarily based on experimental modelling approaches such as patient-level data or disease epidemiology for any key indications , number of procedures and install base analysis for any equipment to obtain precise market estimations  for the base year as well as in historic data analysis. Bottom-up approach is always used to obtain Injectable Bone Graft Substitutes insightful data for the specific country/regions.

The country specific data is again analyzed to derive data at a global level. Specific factors/parameters are considered related to the individual Injectable Bone Graft Substitutes market and quantified with insightful rationale.

Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts at Fact.MR to arrive at various estimations and projections for Sales & Demand of Injectable Bone Graft Substitutes, its market share, production footprint, current launches, agreements, ongoing R&D projects, and market strategies.

To get in-depth insights Request for Brochure here –https://www.factmr.com/connectus/sample?flag=B&rep_id=1272

Injectable Bone Graft Substitutes Market: Segmentation

The global injectable bone graft substitutes market is segmented on the basis of type, application, and end users.

Based on the type, the global injectable bone graft substitutes market is segmented as:

  • Bone Morphogenic Proteins (BMP)
  • Synthetic Bone Grafts

Based on application, the global injectable bone graft substitutes market is segmented as:

  • Joint Reconstruction
  • Spinal Fusion
  • Dental Bone Grafting
  • Craniomaxillofacial
  • Foot and Ankle
  • Long Bone

Based on end users, the global injectable bone graft substitutes market is segmented as:

  • Hospitals
  • Ambulatory Surgical Centers
  • Emergency Rooms
  • Others

The latest market research report analyzes Injectable Bone Graft Substitutes Market demand by Different segments. Providing business leaders with insights On Injectable Bone Graft Substitutes And how they can increase their market share.

We leverage space-age industrial and digitalization tools to provide avant-garde actionable Injectable Bone Graft Substitutes Market insights to our clients.

SWOT analysis has been performed in the market study to investigate the strengths, weaknesses, opportunities and threats of each player, both at global and regional levels.

The Market insights of Injectable Bone Graft Substitutes will improve the revenue impact of businesses in various industries by:

  • Providing a framework tailored toward understanding the attractiveness quotient of various products/solutions/technologies in the Injectable Bone Graft Substitutes Market
  • Guiding stakeholders to identify key problem areas pertaining to their consolidation strategies in the global Injectable Bone Graft Substitutes market and offers solutions
  • Assessing the impact of changing regulatory dynamics in the regions in which companies are keen on expanding their footprints
  • Provides understanding of disruptive technology trends to help businesses make their transitions smoothly
  • Helping leading companies make strategy recalibrations ahead of their competitors and peers
  • Offers insights into promising synergies for top players aiming to retain their leadership position in the market & supply side analysis of Injectable Bone Graft Substitutes market .

The latest industry analysis and survey on Injectable Bone Graft Substitutes provides sales outlook in 20+ countries, across key categories. Insights and outlook on Injectable Bone Graft Substitutes market drivers, trends, and influencing factors are also included in the study.

Request Customized Report as Per Your Requirements https://www.factmr.com/connectus/sample?flag=RC&rep_id=1272

Injectable Bone Graft Substitutes Market: Key Participants

The major players operating in global injectable bone graft substitutes market include DePuy Synthes, Medtronic PLC, Nuvasive, Inc., Orthofix Holdings, Inc., Wright Medical Group N.V., AlloSource, Inc., and Stryker Corporation. To remain in the forefront of the competitive market, leading market players are focusing on expanding their geographical presence and investing in product development.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Moreover, it also gives meaningful as well as actionable insights on the competitive analysis of Injectable Bone Graft Substitutes Market that are developing the current market scenario and which will be lucrative for the future demand of Injectable Bone Graft Substitutes Market.

Crucial insights in Injectable Bone Graft Substitutes market research report:

  • Underlying macro- and microeconomic factors impacting the Sales of Injectable Bone Graft Substitutes market.
  • Basic overview of the Injectable Bone Graft Substitutes, including market definition, classification, and applications.
  • Scrutinization of each market player based on mergers & acquisitions, R&D projects, and product launches.
  • Adoption trend and supply side analysis of Injectable Bone Graft Substitutes across various industries.
  • Important regions and countries offering lucrative opportunities to market stakeholders.

The Demand of Injectable Bone Graft Substitutes Market study includes the current market scenario on the global platform and also Sales of Injectable Bone Graft Substitutes Market development during the forecast period.

Enquiry Before Buying –https://www.factmr.com/connectus/sample?flag=EB&rep_id=1272

List of the Leading Companies Profiled in the Injectable Bone Graft Substitutes Market are:

To provide decision-makers with credible insights on their competitive landscape, the Injectable Bone Graft Substitutes Market industry research report includes detailed competitive landscape analysis.

The competitive landscape analysis for Injectable Bone Graft Substitutes Market includes detailed profiles of Tier 1, Tier 2, and Tier 3 players. The respective market share of Injectable Bone Graft Substitutes manufacturers is provided so business leaders can understand the market scenario.

Browse More Reports by Fact.MR : –https://www.biospace.com/article/anterior-cervical-plating-market-driven-by-rising-number-of-cases-requiring-cervical-fusion-surgery-fact-mr/

An assessment on the winning strategies of key Injectable Bone Graft Substitutes Market manufacturers is provided, with recommendation on what works well in Injectable Bone Graft Substitutes Market landscape.

The global market for injectable bone graft substitute is segmented in terms of type, applications, and end users. Preference for minimally invasive treatment procedures has encouraged manufacturers to develop injectable bone graft substitutes globally.

More Related Reports By Fact.MR On Healthcare : 

Veterinary Endodontics Market :_Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Therapeutic Support Surface Market:- Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

Computer-Assisted Orthopedic Surgery Market :-Forecast, Trend Analysis & Competition Tracking – Global Review 2021 to 2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com